308 related articles for article (PubMed ID: 35579806)
21. Interventional Radiology ex-machina: impact of Artificial Intelligence on practice.
Gurgitano M; Angileri SA; Rodà GM; Liguori A; Pandolfi M; Ierardi AM; Wood BJ; Carrafiello G
Radiol Med; 2021 Jul; 126(7):998-1006. PubMed ID: 33861421
[TBL] [Abstract][Full Text] [Related]
22. Artificial Intelligence in Pharmacovigilance: Scoping Points to Consider.
Hauben M; Hartford CG
Clin Ther; 2021 Feb; 43(2):372-379. PubMed ID: 33478803
[TBL] [Abstract][Full Text] [Related]
23. On the creation of a clinical gold standard corpus in Spanish: Mining adverse drug reactions.
Oronoz M; Gojenola K; Pérez A; de Ilarraza AD; Casillas A
J Biomed Inform; 2015 Aug; 56():318-32. PubMed ID: 26141794
[TBL] [Abstract][Full Text] [Related]
24. Comment on: "Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts".
Magge A; Sarker A; Nikfarjam A; Gonzalez-Hernandez G
J Am Med Inform Assoc; 2019 Jun; 26(6):577-579. PubMed ID: 31087070
[No Abstract] [Full Text] [Related]
25. Integrating clinical pharmacology and artificial intelligence: potential benefits, challenges, and role of clinical pharmacologists.
Singh H; Nim DK; Randhawa AS; Ahluwalia S
Expert Rev Clin Pharmacol; 2024 Apr; 17(4):381-391. PubMed ID: 38340012
[TBL] [Abstract][Full Text] [Related]
26. An adverse drug effect mentions extraction method based on weighted online recurrent extreme learning machine.
El-Allaly ED; Sarrouti M; En-Nahnahi N; Ouatik El Alaoui S
Comput Methods Programs Biomed; 2019 Jul; 176():33-41. PubMed ID: 31200909
[TBL] [Abstract][Full Text] [Related]
27. Convergence of Artificial Intelligence and Neuroscience towards the Diagnosis of Neurological Disorders-A Scoping Review.
Surianarayanan C; Lawrence JJ; Chelliah PR; Prakash E; Hewage C
Sensors (Basel); 2023 Mar; 23(6):. PubMed ID: 36991773
[TBL] [Abstract][Full Text] [Related]
28. Artificial Intelligence for Drug Toxicity and Safety.
Basile AO; Yahi A; Tatonetti NP
Trends Pharmacol Sci; 2019 Sep; 40(9):624-635. PubMed ID: 31383376
[TBL] [Abstract][Full Text] [Related]
29. Artificial Intelligence in Drug Formulation and Development: Applications and Future Prospects.
Noorain ; Srivastava V; Parveen B; Parveen R
Curr Drug Metab; 2023; 24(9):622-634. PubMed ID: 37779408
[TBL] [Abstract][Full Text] [Related]
30. A review on patient-specific facial and cranial implant design using Artificial Intelligence (AI) techniques.
Memon AR; Li J; Egger J; Chen X
Expert Rev Med Devices; 2021 Oct; 18(10):985-994. PubMed ID: 34404280
[TBL] [Abstract][Full Text] [Related]
31. Artificial Intelligence, Machine Learning, Deep Learning, and Cognitive Computing: What Do These Terms Mean and How Will They Impact Health Care?
Bini SA
J Arthroplasty; 2018 Aug; 33(8):2358-2361. PubMed ID: 29656964
[TBL] [Abstract][Full Text] [Related]
32. Implementing Artificial Intelligence and Digital Health in Resource-Limited Settings? Top 10 Lessons We Learned in Congenital Heart Defects and Cardiology.
Thomford NE; Bope CD; Agamah FE; Dzobo K; Owusu Ateko R; Chimusa E; Mazandu GK; Ntumba SB; Dandara C; Wonkam A
OMICS; 2020 May; 24(5):264-277. PubMed ID: 31592719
[TBL] [Abstract][Full Text] [Related]
33. How Cognitive Machines Can Augment Medical Imaging.
Miller DD; Brown EW
AJR Am J Roentgenol; 2019 Jan; 212(1):9-14. PubMed ID: 30422716
[TBL] [Abstract][Full Text] [Related]
34. Detecting adverse drug reactions in discharge summaries of electronic medical records using Readpeer.
Tang Y; Yang J; Ang PS; Dorajoo SR; Foo B; Soh S; Tan SH; Tham MY; Ye Q; Shek L; Sung C; Tung A
Int J Med Inform; 2019 Aug; 128():62-70. PubMed ID: 31160013
[TBL] [Abstract][Full Text] [Related]
35. Enabling pregnant women and their physicians to make informed medication decisions using artificial intelligence.
Davidson L; Boland MR
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):305-318. PubMed ID: 32279157
[TBL] [Abstract][Full Text] [Related]
36. Behind the scenes: A medical natural language processing project.
Wu JT; Dernoncourt F; Gehrmann S; Tyler PD; Moseley ET; Carlson ET; Grant DW; Li Y; Welt J; Celi LA
Int J Med Inform; 2018 Apr; 112():68-73. PubMed ID: 29500024
[TBL] [Abstract][Full Text] [Related]
37. Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts.
Cocos A; Fiks AG; Masino AJ
J Am Med Inform Assoc; 2017 Jul; 24(4):813-821. PubMed ID: 28339747
[TBL] [Abstract][Full Text] [Related]
38. Artificial intelligence approaches to predicting and detecting cognitive decline in older adults: A conceptual review.
Graham SA; Lee EE; Jeste DV; Van Patten R; Twamley EW; Nebeker C; Yamada Y; Kim HC; Depp CA
Psychiatry Res; 2020 Feb; 284():112732. PubMed ID: 31978628
[TBL] [Abstract][Full Text] [Related]
39. Artificial Intelligence in Medical Practice: The Question to the Answer?
Miller DD; Brown EW
Am J Med; 2018 Feb; 131(2):129-133. PubMed ID: 29126825
[TBL] [Abstract][Full Text] [Related]
40. Artificial intelligence for oral and maxillo-facial surgery: A narrative review.
Rasteau S; Ernenwein D; Savoldelli C; Bouletreau P
J Stomatol Oral Maxillofac Surg; 2022 Jun; 123(3):276-282. PubMed ID: 35091121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
